Clinical Trial for Lung Cancer Treatment Brings Good News for Eli Lilly

A clinical trial for Eli Lilly’s necitumumab showed the lung cancer drug increases patient survival, skyrocketing past low expectations from Wall Street analysts skeptical of the drug after safety concerns stopped a previous trial.
Drug Industry Daily